TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MDRX

Veradigm Inc.

Healthcare · Health Information Services

5.00$ +2.9% vs. previous close Closing price · As of: Sep 24, 2026

Ownership

Ownership Structure

Who owns Veradigm Inc. (MDRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 74.5% of the shares are freely tradable; institutional investors hold 62.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 62.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 4.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 74.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 14.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 109Mio.

Largest Shareholders

Funds

Funds MDRX
Name Stake (%) Shares Change (%) Date
Vanguard Explorer Value Inv 0.78 848,195 +20.7 06/30/2026
Hartford Small Cap Value Y 0.50 549,911 +0.0 07/31/2026
Royce Micro-Cap Trust 0.45 490,385 +428.5 06/30/2026
NYLIM VP Wellington Small Cap Initial 0.21 228,051 +0.0 07/31/2026
Royce Micro-Cap Invmt 0.19 205,758 +375.2 06/30/2026
Royce Small-Cap Trust 0.14 153,900 +0.0 06/30/2026
Wellington Absolute Return Global Equity 0.06 67,949 +0.0 03/31/2026
Wellington ARGE (Hedged to GBP) 0.06 67,949 +0.0 03/31/2026
Royce Capital Micro-Cap Inv 0.06 67,843 +387.9 06/30/2026
Wellington Hedged Alpha Opportunities 0.05 49,608 +0.0 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?